D
Discure Technologies
Breakthrough bioelectronic solutions for minimally invasive treatment of low back pain and degenerative disc disease
About Discure Technologies
Discure is a pioneering company in the MedTech industry, focusing on developing minimally invasive, bioelectronic solutions to treat low back pain and degenerative disc disease. The company serves patients suffering from spinal and synovial joint issues, aiming to provide effective treatments without the need for hospitalization or rehabilitation. Discure operates in the global healthcare market, targeting both Europe and North America, where it is currently running clinical trials. The business model revolves around the development and commercialization of its unique disc regeneration system, which has received FDA Breakthrough Device designation, facilitating faster market access. Revenue is generated through the sale and licensing of its medical devices. Discure has been recognized with multiple awards, including the Orthopedics This Week award for New Technology and has been a finalist in several prestigious MedTech and HealthTech competitions. The company boasts an experienced management team and a panel of renowned scientific and clinical expert advisors, ensuring the highest standards in research and development.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Emek HaYarden Regional Council, Israel
- Employees
- 13
- Open positions
- 1
- Dealroom signal
- 57.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Rehabilitation, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2024 | $11M | $44M | Supernova Invest · Bold Capital Partners · Sanara Ventures | ↗ |
Growth signals
Latest recorded traffic for Discure Technologies is 1.3K monthly website visits, up 550% over the last three months. Discure Technologies's team grew 30% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Supernova Invest
Bold Capital Partners
Sanara Ventures
Other known investors1 additional known investor
Agile Capital Markets
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Discure Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Discure Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.